Episodes

  • etatse laer dna sevitanretla rof esac eht :yenom ruoy gniganam

    etatse laer dna sevitanretla rof esac eht :yenom ruoy gniganam
    Oct 25 2022
    Join Barron’s senior writer Lauren Foster and Jeff Schwaber, CEO of Bluerock Capital Markets, an alternative investment platform, for a conversation about the role that alternatives and real estate can play in a portfolio, which real estate sectors look attractive in the current environment, and the benefits of interval funds for retail investors.
    Show More Show Less
    32 mins
  • erom dna ,aznanob sgninrae hcet ,ffolles gib s'anihc :hctaw ot skcots

    erom dna ,aznanob sgninrae hcet ,ffolles gib s'anihc :hctaw ot skcots
    Oct 24 2022
    Barron's senior managing editor Lauren R. Rublin and deputy editor Ben Levisohn discuss the China market selloff, trouble for EV makers, tech giants' earnings, and the outlook for industrials and utilities.
    Show More Show Less
    38 mins
  • ?pmup eht ta secirp sag rewol yllaer sevreser lio fo esaeler eht lliw

    ?pmup eht ta secirp sag rewol yllaer sevreser lio fo esaeler eht lliw
    Oct 21 2022
    Can consumers expect lower prices at the gasoline pump in response to the release of more oil from the Strategic Petroleum Reserve? Join as Myra Saefong, senior reporter at MarketWatch, interviews Tom Kloza, global head of energy analysis at OPIS, an energy information and data provider. Examine the forces that are driving retail gasoline prices and what consumers should expect to pay in the coming months.
    Show More Show Less
    41 mins
  • gnitsevni erachtlaeh no etadpu na

    gnitsevni erachtlaeh no etadpu na
    Oct 20 2022
    Barron's deputy editor Ben Levisohn and healthcare industry reporter Josh Nathan-Kazis discuss the outlook for healthcare stocks, and the latest news on Covid-19 treatments and vaccines.
    Show More Show Less
    32 mins
  • gnitsevni erachtlaeh no etadpu na

    gnitsevni erachtlaeh no etadpu na
    Oct 20 2022
    Barron's deputy editor Ben Levisohn and healthcare industry reporter Josh Nathan-Kazis discuss the outlook for healthcare stocks, and the latest news on Covid-19 treatments and vaccines.
    Show More Show Less
    32 mins
  • ?deracs gninnur remusnoc nacirema eht si - hctawtekram

    ?deracs gninnur remusnoc nacirema eht si - hctawtekram
    Oct 19 2022
    Quentin Fottrell, managing editor, personal finance at MarketWatch, will talk to MarketWatch economics editor Gregory Robb about the impact inflation and economic uncertainty is having on the U.S. shopper in the runup to the holiday season, and whether their anxieties are justified.
    Show More Show Less
    32 mins
  • skcots ygolonhcet rof kooltuo eht - redart hcet

    skcots ygolonhcet rof kooltuo eht - redart hcet
    Oct 18 2022
    Barron's associate editor for technology Eric Savitz speaks with long-time tech fund manager and finance professor Paul Meeks on the outlook for technology stocks. 
    Show More Show Less
    35 mins
  • gnivorpmi si erutcip eht :hctaw ot skcots

    gnivorpmi si erutcip eht :hctaw ot skcots
    Oct 17 2022
    Barron's senior managing editor Lauren R. Rublin, deputy editor Ben Levisohn and Barry Bannister, managing director and chief equity strategist at Stifel, discuss what's behind the recent rally, the outlook for bank stocks and bonds, and what to buy in a range-bound market.
    Show More Show Less
    42 mins